Neurologic Manifestations  >>  topiramate  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
topiramate / Generic mfg.
NCT00233012: A Study of the Pharmacokinetics, Safety and Tolerability of Topiramate in Infants (Age 1-24 Months) With Refractory Partial-onset Seizures

Completed
1
16
US
Topiramate
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Seizures
 
10/07

Download Options